FIGURE 1.

Study design. ^aBefore dosing on day 1 of study period 1, participants were randomized in a ratio of 1:1 to one of two treatment sequences (AB and BA). Participants received each treatment on one occasion. ^bEach trazpiroben dosing was separated by at least 7 days from the time of study period 1 trazpiroben administration. ^cParticipants were confined from check‐in until after the 48‐h post‐trazpiroben‐dose blood draw during each study period. ^dTrazpiroben administration was defined as hour 0. PK, pharmacokinetic